Research exec leaves Progenics Pharmaceuticals
-
- May
- 23
Progenics Pharmaceuticals Inc. of Eastview said in a filing with the Securities and Exchange Commission that Dr. Alton B. Kremer, its senior vice president of clinical research, had resigned on May 20 to pursue other interests.
Kremer had joined the company in October 2004. Last year he was paid $380,000 in salary and a $245,000 bonus, among other compensation, according to Progenics’ proxy statement.
This entry was posted
on Friday, May 23rd, 2008 at 10:46 am by Jerry Gleeson.
You can follow any responses to this entry through the RSS 2.0 feed.
Share and Enjoy: 
| 
Print
| 
Email
Advertisement
